- Home
- REXR vs BMRN Comparison
REXR vs BMRN Comparison
Compare REXR & BMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | REXR | BMRN |
|---|---|---|
| Founded | 2013 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.7B | 10.0B |
| IPO Year | 2013 | 1999 |
Fundamental Metrics
Financial Performance| Metric | REXR | BMRN |
|---|---|---|
| Price | $40.42 | $56.31 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 10 | 20 |
| Target Price | $43.22 | ★ $90.15 |
| AVG Volume (30 Days) | ★ 2.2M | 2.1M |
| Earning Date | 02-04-2026 | 02-18-2026 |
| Dividend Yield | ★ 4.24% | N/A |
| EPS Growth | 15.85 | ★ 59.53 |
| EPS | 1.43 | ★ 2.68 |
| Revenue | $997,931,000.00 | ★ $3,094,001,000.00 |
| Revenue This Year | $8.18 | $13.49 |
| Revenue Next Year | $1.88 | $9.73 |
| P/E Ratio | $28.44 | ★ $21.09 |
| Revenue Growth | 10.40 | ★ 12.39 |
| 52 Week Low | $29.68 | $50.76 |
| 52 Week High | $44.38 | $73.51 |
Technical Indicators
Market Signals| Indicator | REXR | BMRN |
|---|---|---|
| Relative Strength Index (RSI) | 53.50 | 47.33 |
| Support Level | $38.71 | $55.50 |
| Resistance Level | $40.04 | $57.33 |
| Average True Range (ATR) | 0.81 | 1.59 |
| MACD | 0.04 | -0.16 |
| Stochastic Oscillator | 60.75 | 44.81 |
Price Performance
Historical ComparisonAbout REXR Rexford Industrial Realty Inc.
Rexford Industrial Realty Inc is a real estate investment trust engaged in owning, operating, and acquiring industrial properties in Southern California infill markets. The goal is to generate attractive risk-adjusted returns for stockholders by providing superior access to industrial property investments in Southern California infill markets. It has one operating segment business of investing in, operating, and repositioning/redeveloping industrial real estate properties located in Southern California infill markets.
About BMRN BioMarin Pharmaceutical Inc.
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.